These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20371706)

  • 1. Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.
    Wang M; Cooper PR; Jiang M; Zhao H; Hui Y; Yao Y; Tate JC; Damera G; Lawson JA; Jester WF; Haczku A; Panettieri RA; FitzGerald GA
    J Pharmacol Exp Ther; 2010 Jul; 334(1):63-8. PubMed ID: 20371706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
    Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
    Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
    Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.
    Wang M; Lee E; Song W; Ricciotti E; Rader DJ; Lawson JA; Puré E; FitzGerald GA
    Circulation; 2008 Mar; 117(10):1302-9. PubMed ID: 18285567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    FASEB J; 2006 Nov; 20(13):2387-9. PubMed ID: 17023389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile.
    Boulet L; Ouellet M; Bateman KP; Ethier D; Percival MD; Riendeau D; Mancini JA; Méthot N
    J Biol Chem; 2004 May; 279(22):23229-37. PubMed ID: 15016822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Pollastro F; Northoff H; Werz O
    Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury.
    Wang M; Ihida-Stansbury K; Kothapalli D; Tamby MC; Yu Z; Chen L; Grant G; Cheng Y; Lawson JA; Assoian RK; Jones PL; Fitzgerald GA
    Circulation; 2011 Feb; 123(6):631-9. PubMed ID: 21282500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction.
    Degousee N; Fazel S; Angoulvant D; Stefanski E; Pawelzik SC; Korotkova M; Arab S; Liu P; Lindsay TF; Zhuo S; Butany J; Li RK; Audoly L; Schmidt R; Angioni C; Geisslinger G; Jakobsson PJ; Rubin BB
    Circulation; 2008 Apr; 117(13):1701-10. PubMed ID: 18347209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.
    Kapoor M; Kojima F; Qian M; Yang L; Crofford LJ
    J Biol Chem; 2007 Feb; 282(8):5356-66. PubMed ID: 17186945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation.
    Lundequist A; Nallamshetty SN; Xing W; Feng C; Laidlaw TM; Uematsu S; Akira S; Boyce JA
    J Immunol; 2010 Jan; 184(1):433-41. PubMed ID: 20028661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1.
    Guay J; Bateman K; Gordon R; Mancini J; Riendeau D
    J Biol Chem; 2004 Jun; 279(23):24866-72. PubMed ID: 15044444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
    Wang M; Song WL; Cheng Y; Fitzgerald GA
    J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
    Claveau D; Sirinyan M; Guay J; Gordon R; Chan CC; Bureau Y; Riendeau D; Mancini JA
    J Immunol; 2003 May; 170(9):4738-44. PubMed ID: 12707354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 produced by microsomal prostaglandin E synthase-1 regulates the onset and the maintenance of wakefulness.
    Takemiya T
    Neurochem Int; 2011 Nov; 59(6):922-4. PubMed ID: 21784115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis.
    Sasaki Y; Kamei D; Ishikawa Y; Ishii T; Uematsu S; Akira S; Murakami M; Hara S
    Oncogene; 2012 Jun; 31(24):2943-52. PubMed ID: 21986945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction.
    Jia Z; Wang H; Yang T
    Hypertension; 2012 Jan; 59(1):122-8. PubMed ID: 22106404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
    Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
    J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.